Apoptosis Market Analysis - Forecast(2022 - 2027)

Apoptosis Market size in 2019 is estimated to be $ 3570 million, growing at a CAGR of 6% during the forecast period 2022-2027. Apoptosis is a programmed natural process of cell death in the body which results from natural stimuli in order to protect against viral infection, unusual cell division and cells with damaged genetic material. The morphological features of apoptotic cells are the compaction of nuclear chromatin, the contraction of cytoplasm and production of membrane-bound apoptotic bodies. Increasing Cancer cases and technological advancement are the major factors driving the growth of the market. Moreover, rising disposable income and advancement of R&D activities further enhance the overall market demand for apoptosis during the forecast period 2022-2027.

Report Coverage

The report: "Apoptosis Market - Forecast (2022-2027)", by IndustryARC, covers an in-depth analysis of the following segments of the Apoptosis Market:

By Product : Kits, Reagents

By Assay Type : Caspase, DNA Fragmentation, Annexin V.

By Technology : Flow Cytometry, Florescence Microscopy.

By Mechanism : Bcl-2 Modulators, p53 Modulators, Others.

By Class of Drugs : Direct Apoptogens, First Generation Indirect Apoptogens, Second Generation Indirect Apoptogens.

By Disease Treatment : Cancer, Neurodegenerative Disease, Cardiovascular Disease, Others.

By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Key Takeaways

In 2019, North America dominates the Apoptosis Market owing to increasing incidence of chronic disease and increasing investment for cancer research.

Increasing cancer cases and technological advancement is driving the market growth of apoptosis.

Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Apoptosis Market report.

Lack of skilled professional are challenging the growth of the market.

Apoptosis Market Segment Analysis - By Product

Based on the Product, Apoptosis Market is segmented into Kits, Reagents. The kits segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 5.5% during the forecast period 2022-2027. This is mainly owing to increasing adoption of apoptosis kits which increases the manufacturing of product are contributing to the growth of this segment.

Apoptosis Market Segment Analysis - By Technology

Based on the Technology, Apoptosis Market is segmented into Flow Cytometry, Florescence Microscopy. In 2019, flow cytometry held the largest share in the Apoptosis Market.The technique helps in making a clear distinction between intact mitochondria (healthy cells) and permeabilized mitochondria (cells undergoing death and are contributing to the growth of this segment.

Apoptosis Market Segment Analysis - Geography

North America dominated the Market share accounting for 45% of the market in 2019. This is mainly owing to increasing incidence of chronic disease and increasing investment for cancer research. According to National Cancer Institute about 1 million cases of cancer are diagnosed in the U.S. which are contributing the growth of this segment.

However, the Asia Pacific region is projected to be the fastest-growing during the forecast period 2022-2027. This is owing to increasing disposable income and increasing healthcare expenditure.

Apoptosis Market Drivers

Increasing Cancer Cases

Increasing cancer cases and rising chronic disease are some factors driving the market growth of this segment. According to World Health Organization, about 18 million people are suffering from cancer which are increasing the market growth of apoptosis.

Technological Advancement

Increasing technological advancement and rising research in medical are some factor driving the growth of the market. Moreover, increasing research and development activities helps to develop new treatments for multiple diseases are contributing to the growth of Apoptosis Market.

Apoptosis Market - Challenges

Lack of skilled professional are challenging the growth of the market. Moreover, lack of awareness among are further restraining its market growth during the forecast period 2022-2027.

Apoptosis Industry Outlook

Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Apoptosis Market. Apoptosis top 10 companies are Danaher Corporation, BioTek Instruments, Promega Corporation, PerkinElmer, Abcam plc, Abnova, Creative Bioarray, Thermo Fisher Scientific, Merck KgaA, Becton, GE Healthcare, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius.

Acquisitions/Product Launches:

On April 2018, Thermo Fisher Scientific launches Multiskan Sky Microplate Spectrophotometer which is designed for photometric research.

On 2 January 2017, Dickinson and Company has acquisition with Becton for the development in healthcare sector.